Europe Sex Reassignment Surgery Market by Surgery Type, Surgical Procedure, End User, Countries and Company Analysis 2026-2034
Description
Europe Sex Reassignment Surgery Market Size & Forecast 2026-2034
The Europe Sex Reassignment Surgery Market is projected to witness steady growth over the forecast period, driven by increasing awareness of gender-affirming healthcare, improving access to specialized medical services, and growing social acceptance across European countries. The Europe Sex Reassignment Surgery market is expected to expand from US$ 0.85 billion in 2025 to US$ 1.92 billion in 2034, registering a compound annual growth rate (CAGR) of 9.52% from 2026 to 2034. Advancements in surgical techniques, supportive healthcare policies, and rising demand for comprehensive gender-affirming treatments are key factors supporting market expansion.
Europe Sex Reassignment Surgery Market Outlook
Sex reassignment surgery (SRS), also known as gender-affirming surgery, refers to a set of medical procedures that help align an individual’s physical characteristics with their gender identity. These procedures may include chest or breast surgery, genital reconstruction, facial feminization or masculinization, and other reconstructive interventions. SRS is typically part of a broader gender-affirming care pathway that can also involve psychological support, hormone therapy, and long-term medical follow-up. The goal of sex reassignment surgery is to reduce gender dysphoria and improve overall quality of life, mental well-being, and social functioning for transgender and gender-diverse individuals.
In Europe, the popularity of sex reassignment surgery has grown steadily over the past decade. This growth is supported by increasing social acceptance of transgender identities, stronger advocacy for LGBTQ+ rights, and improved access to specialized healthcare services. Several European countries have integrated gender-affirming care into public or semi-public healthcare systems, making procedures more accessible. Advancements in surgical techniques, higher standards of post-operative care, and greater public awareness have also contributed to rising demand for sex reassignment surgery across Europe.
Growth Drivers in the Europe Sex Reassignment Surgery Market
Increasing Social Acceptance and Legal Recognition
Growing social acceptance of transgender and gender-diverse individuals across Europe is a major driver of the sex reassignment surgery market. Many European countries have strengthened legal protections related to gender identity, anti-discrimination, and healthcare access. Legal recognition of gender change has encouraged more individuals to seek medical and surgical gender-affirming treatments without fear of social or institutional barriers. Public awareness campaigns, advocacy groups, and media representation have further reduced stigma, allowing individuals to pursue surgery as part of their transition journey. As social acceptance improves, demand for professional, high-quality surgical services increases. This shift is particularly visible in urban centers where inclusive healthcare frameworks and specialized providers are more accessible. According to the FRA survey, there has been a significant increase in hate-motivated harassment targeting LGBTIQ people, with more than half reporting that they had experienced this (55%, up 18 percentage points since 2019). Respondents in most EU countries also reported more frequent physical and sexual attacks, particularly affecting trans, non-binary, gender-diverse and intersex people.The European Union has to be at the forefront of efforts to better protect LGBTIQ+ people’s rights. In November 2020 the Commission adopted the LGBTIQ Equality Strategy 2020-2025, which was the first-ever Commission strategy on LGBTIQ equality and delivered on the European Commission's commitment to building a Union of Equality.
Improved Access to Gender-Affirming Healthcare Services
Access to specialized gender-affirming healthcare has expanded significantly in Europe, driving growth in the SRS market. Several European healthcare systems now include partial or full coverage for sex reassignment procedures, reducing financial barriers for patients. Multidisciplinary care models integrating psychological evaluation, hormone therapy, and surgical planning have improved patient outcomes and confidence in pursuing surgery. The establishment of dedicated gender clinics and specialized hospital departments has also shortened wait times and improved procedural availability. Increased training and specialization among surgeons further enhance the quality and safety of procedures. Nov 2024, Nearly half of European Union countries consider ‘transsexualism’ a psychiatric diagnosis required for trans people to access specific healthcare, which goes against the World Health Organisation (WHO) guidelines. Almost half of the EU - 12 of its 27 member states - don’t follow World Health Organisation guidelines for recognition of trans identities, according to a new health map published by TGEU, an umbrella non-profit advocating for the rights and wellbeing of trans people.
Advancements in Surgical Techniques and Post-Operative Care
Technological and procedural advancements are significantly contributing to the expansion of the Europe SRS market. Modern surgical techniques offer improved functional and aesthetic outcomes, reduced complication rates, and shorter recovery times. Innovations in microsurgery, reconstructive techniques, and minimally invasive procedures have enhanced patient satisfaction and long-term results. Improved post-operative care protocols, including physical therapy and follow-up services, further support recovery and quality of life. These advancements increase trust in surgical outcomes, encouraging more individuals to pursue surgery. August 2022, Lithuania released the long-pending Order on the Approval of the Description of Procedures for the Diagnosis and Treatment of Gender Identity Disorder (Transexualism). The protocol lays down, for the first time, the guidelines or steps to be followed by medical professionals when providing trans specific healthcare and regulates the provision of healthcare services. While it is a significant step forward for Lithuania, the protocol has several key limitations – such as requirement of a psychiatric diagnosis, lack of an informed consent model, and no access to surgical healthcare – which can negatively impact trans peoples’ access to healthcare.
Challenges in the Europe Sex Reassignment Surgery Market
Uneven Access and Long Waiting Periods
A major challenge in the European SRS market is unequal access to services across countries and regions. While some nations offer comprehensive gender-affirming healthcare, others face limited infrastructure, specialist shortages, and lengthy waiting lists. Public healthcare systems often struggle to meet rising demand, leading to delays that can extend for several years. These long waiting periods can negatively impact mental health and overall patient well-being. Geographic disparities force some patients to seek treatment abroad or rely on private clinics, increasing financial and logistical burdens. Addressing these access gaps remains a critical challenge for equitable market development across Europe.
Regulatory and Ethical Complexity
Sex reassignment surgery in Europe is subject to complex regulatory, ethical, and medical guidelines that vary by country. Differences in eligibility criteria, psychological assessment requirements, and consent processes create inconsistencies in care delivery. Navigating these regulations increases administrative complexity for providers and may discourage new entrants into the market. Ethical debates surrounding age requirements and informed consent further complicate policy frameworks. These regulatory challenges can slow service expansion and limit patient access, restraining overall market growth despite rising demand.
Europe Male-to-Female Sex Reassignment Surgery Market
Male-to-female (MTF) procedures represent one of the largest segments of the Europe SRS market. These procedures include genital reconstruction, breast augmentation, facial feminization, and voice modification surgeries. Demand is driven by a growing number of transgender women seeking comprehensive physical alignment with gender identity. Advances in surgical precision and aesthetic outcomes have improved satisfaction rates, encouraging wider adoption. Multistage surgical planning and long-term follow-up care further support patient confidence. As awareness and access increase, the MTF segment continues to account for a significant share of overall SRS procedures in Europe.
Europe Augmentation Mammoplasty Surgery Market
Augmentation mammoplasty is a key component of gender-affirming surgery for transgender women in Europe. While hormone therapy can promote breast development, many individuals seek surgical enhancement to achieve desired size and symmetry. Improvements in implant materials and surgical techniques have increased safety and aesthetic appeal. Demand is supported by rising acceptance of combined surgical approaches that address multiple aspects of physical transition. This segment benefits from shorter recovery times and relatively high satisfaction rates, making it a widely requested procedure within the broader SRS market.
Europe Genital Surgery Market
Genital surgery represents a central segment of the Europe SRS market, encompassing procedures such as vaginoplasty, phalloplasty, and metoidioplasty. These surgeries are often considered essential for alleviating gender dysphoria and improving quality of life. High procedural complexity requires specialized surgical expertise and multidisciplinary care teams. Continued innovation in reconstructive techniques has improved functional outcomes and reduced complications. Despite high costs and long waiting lists, demand for genital surgery remains strong across Europe.
Europe Voice & Airway Surgery Market
Voice and airway surgery is an increasingly important segment of the European SRS market, particularly for transgender women. Voice pitch and resonance play a critical role in gender expression and social interaction. Surgical interventions complement voice therapy to help individuals achieve vocal characteristics aligned with their gender identity. Growing recognition of voice as a key aspect of transition has increased demand for these procedures. Specialized ENT surgeons and speech therapists support this expanding market segment.
Europe Sex Reassignment Surgery Hospitals Market
Hospitals represent a major setting for sex reassignment surgeries in Europe, particularly for complex and multi-stage procedures. Hospitals offer access to multidisciplinary teams, advanced surgical infrastructure, and post-operative care facilities. Public hospitals often serve as primary providers under national healthcare systems, while private hospitals cater to self-funded patients. Their ability to manage complications and long-term follow-up strengthens patient trust and market growth.
Europe Sex Reassignment Surgery Specialty Clinics Market
Specialty clinics play a growing role in the European SRS market by offering highly specialized, patient-centered care. These clinics often focus exclusively on gender-affirming procedures, providing streamlined treatment pathways and personalized surgical planning. Shorter waiting times and dedicated expertise attract patients seeking faster access and tailored services. Specialty clinics complement hospital-based care and contribute significantly to overall market expansion.
France Sex Reassignment Surgery Market
The sex reassignment surgery market in France is shaped by increasing social acceptance and integration of gender-affirming care within the public healthcare system. France recognizes gender dysphoria as a legitimate medical condition, enabling access to psychological support, hormone therapy, and surgical procedures through regulated care pathways. Public hospitals play a central role in providing sex reassignment surgeries, particularly for complex procedures such as genital reconstruction. While public coverage reduces financial barriers, demand often exceeds capacity, leading to extended waiting periods. This has encouraged growth in private healthcare providers offering faster access and personalized care. France also benefits from skilled surgeons and multidisciplinary medical teams, improving procedural outcomes and patient confidence. Advocacy efforts and legal protections for transgender individuals further support market growth. Overall, the French market demonstrates steady expansion driven by healthcare inclusion, clinical expertise, and rising awareness of gender-affirming treatment options.
United Kingdom Sex Reassignment Surgery Market
The United Kingdom sex reassignment surgery market operates within a structured healthcare framework that emphasizes multidisciplinary assessment and long-term patient support. Gender-affirming surgeries are typically accessed through specialized clinics and hospitals, following defined evaluation and referral pathways. Public healthcare provision plays a significant role, making surgery accessible to many patients; however, long waiting lists remain a major challenge. As a result, private clinics have expanded to meet unmet demand, offering shorter timelines and broader procedural options. Increasing awareness, social acceptance, and legal recognition of transgender rights continue to drive demand for surgical interventions. The UK market also benefits from experienced surgeons and growing specialization in gender-affirming procedures. Despite access challenges, the combination of public and private healthcare provision supports steady market growth, positioning the UK as a key contributor to the European sex reassignment surgery landscape.
Germany Sex Reassignment Surgery Market
Germany represents one of the most advanced sex reassignment surgery markets in Europe, supported by a strong healthcare infrastructure and high clinical standards. The country offers comprehensive gender-affirming care through both public and private healthcare systems, with access to experienced surgeons and modern surgical facilities. Germany is particularly known for expertise in complex reconstructive procedures, attracting both domestic and international patients. Insurance coverage for sex reassignment surgery reduces financial barriers, although strict assessment and documentation requirements can extend treatment timelines. Multidisciplinary care teams, including surgeons, endocrinologists, and mental health professionals, enhance treatment quality and outcomes. Growing social acceptance and legal recognition of gender diversity further contribute to demand. Overall, Germany’s combination of medical excellence, regulatory clarity, and patient trust supports sustained growth in its sex reassignment surgery market.
Market Segmentation
Surgery Type
• Male-to-Female
• Female-to-Male
Surgical Procedure
• Augmentation Mammoplasty
• Genital Surgery
• Facial Feminisation Surgery
• Facial Masculinisation Surgery
• Voice & Airway Surgery
• Body Contouring & Adjunct Procedures
• Others
End User
• Hospitals
• Specialty Clinics
• Ambulatory Surgery Centres
• Others
Countries
• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherlands
• Russia
• Poland
• Greece
• Norway
• Romania
• Portugal
• Rest of Europe
All companies have been covered with 5 Viewpoints
• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis
Company Analysis
• Mount Sinai Health System
• Boston Medical Center
• Rumer Cosmetic Surgery
• The London Transgender Clinic
• Phuket Plastic Surgery Institute
• Gender Surgery Amsterdam (Netherlands)
• UCSF Transgender Care
• Transgender Surgery Institute of America
• Center for Gender Confirmation Serbia
• Papillon Gender Clinic (UK)
The Europe Sex Reassignment Surgery Market is projected to witness steady growth over the forecast period, driven by increasing awareness of gender-affirming healthcare, improving access to specialized medical services, and growing social acceptance across European countries. The Europe Sex Reassignment Surgery market is expected to expand from US$ 0.85 billion in 2025 to US$ 1.92 billion in 2034, registering a compound annual growth rate (CAGR) of 9.52% from 2026 to 2034. Advancements in surgical techniques, supportive healthcare policies, and rising demand for comprehensive gender-affirming treatments are key factors supporting market expansion.
Europe Sex Reassignment Surgery Market Outlook
Sex reassignment surgery (SRS), also known as gender-affirming surgery, refers to a set of medical procedures that help align an individual’s physical characteristics with their gender identity. These procedures may include chest or breast surgery, genital reconstruction, facial feminization or masculinization, and other reconstructive interventions. SRS is typically part of a broader gender-affirming care pathway that can also involve psychological support, hormone therapy, and long-term medical follow-up. The goal of sex reassignment surgery is to reduce gender dysphoria and improve overall quality of life, mental well-being, and social functioning for transgender and gender-diverse individuals.
In Europe, the popularity of sex reassignment surgery has grown steadily over the past decade. This growth is supported by increasing social acceptance of transgender identities, stronger advocacy for LGBTQ+ rights, and improved access to specialized healthcare services. Several European countries have integrated gender-affirming care into public or semi-public healthcare systems, making procedures more accessible. Advancements in surgical techniques, higher standards of post-operative care, and greater public awareness have also contributed to rising demand for sex reassignment surgery across Europe.
Growth Drivers in the Europe Sex Reassignment Surgery Market
Increasing Social Acceptance and Legal Recognition
Growing social acceptance of transgender and gender-diverse individuals across Europe is a major driver of the sex reassignment surgery market. Many European countries have strengthened legal protections related to gender identity, anti-discrimination, and healthcare access. Legal recognition of gender change has encouraged more individuals to seek medical and surgical gender-affirming treatments without fear of social or institutional barriers. Public awareness campaigns, advocacy groups, and media representation have further reduced stigma, allowing individuals to pursue surgery as part of their transition journey. As social acceptance improves, demand for professional, high-quality surgical services increases. This shift is particularly visible in urban centers where inclusive healthcare frameworks and specialized providers are more accessible. According to the FRA survey, there has been a significant increase in hate-motivated harassment targeting LGBTIQ people, with more than half reporting that they had experienced this (55%, up 18 percentage points since 2019). Respondents in most EU countries also reported more frequent physical and sexual attacks, particularly affecting trans, non-binary, gender-diverse and intersex people.The European Union has to be at the forefront of efforts to better protect LGBTIQ+ people’s rights. In November 2020 the Commission adopted the LGBTIQ Equality Strategy 2020-2025, which was the first-ever Commission strategy on LGBTIQ equality and delivered on the European Commission's commitment to building a Union of Equality.
Improved Access to Gender-Affirming Healthcare Services
Access to specialized gender-affirming healthcare has expanded significantly in Europe, driving growth in the SRS market. Several European healthcare systems now include partial or full coverage for sex reassignment procedures, reducing financial barriers for patients. Multidisciplinary care models integrating psychological evaluation, hormone therapy, and surgical planning have improved patient outcomes and confidence in pursuing surgery. The establishment of dedicated gender clinics and specialized hospital departments has also shortened wait times and improved procedural availability. Increased training and specialization among surgeons further enhance the quality and safety of procedures. Nov 2024, Nearly half of European Union countries consider ‘transsexualism’ a psychiatric diagnosis required for trans people to access specific healthcare, which goes against the World Health Organisation (WHO) guidelines. Almost half of the EU - 12 of its 27 member states - don’t follow World Health Organisation guidelines for recognition of trans identities, according to a new health map published by TGEU, an umbrella non-profit advocating for the rights and wellbeing of trans people.
Advancements in Surgical Techniques and Post-Operative Care
Technological and procedural advancements are significantly contributing to the expansion of the Europe SRS market. Modern surgical techniques offer improved functional and aesthetic outcomes, reduced complication rates, and shorter recovery times. Innovations in microsurgery, reconstructive techniques, and minimally invasive procedures have enhanced patient satisfaction and long-term results. Improved post-operative care protocols, including physical therapy and follow-up services, further support recovery and quality of life. These advancements increase trust in surgical outcomes, encouraging more individuals to pursue surgery. August 2022, Lithuania released the long-pending Order on the Approval of the Description of Procedures for the Diagnosis and Treatment of Gender Identity Disorder (Transexualism). The protocol lays down, for the first time, the guidelines or steps to be followed by medical professionals when providing trans specific healthcare and regulates the provision of healthcare services. While it is a significant step forward for Lithuania, the protocol has several key limitations – such as requirement of a psychiatric diagnosis, lack of an informed consent model, and no access to surgical healthcare – which can negatively impact trans peoples’ access to healthcare.
Challenges in the Europe Sex Reassignment Surgery Market
Uneven Access and Long Waiting Periods
A major challenge in the European SRS market is unequal access to services across countries and regions. While some nations offer comprehensive gender-affirming healthcare, others face limited infrastructure, specialist shortages, and lengthy waiting lists. Public healthcare systems often struggle to meet rising demand, leading to delays that can extend for several years. These long waiting periods can negatively impact mental health and overall patient well-being. Geographic disparities force some patients to seek treatment abroad or rely on private clinics, increasing financial and logistical burdens. Addressing these access gaps remains a critical challenge for equitable market development across Europe.
Regulatory and Ethical Complexity
Sex reassignment surgery in Europe is subject to complex regulatory, ethical, and medical guidelines that vary by country. Differences in eligibility criteria, psychological assessment requirements, and consent processes create inconsistencies in care delivery. Navigating these regulations increases administrative complexity for providers and may discourage new entrants into the market. Ethical debates surrounding age requirements and informed consent further complicate policy frameworks. These regulatory challenges can slow service expansion and limit patient access, restraining overall market growth despite rising demand.
Europe Male-to-Female Sex Reassignment Surgery Market
Male-to-female (MTF) procedures represent one of the largest segments of the Europe SRS market. These procedures include genital reconstruction, breast augmentation, facial feminization, and voice modification surgeries. Demand is driven by a growing number of transgender women seeking comprehensive physical alignment with gender identity. Advances in surgical precision and aesthetic outcomes have improved satisfaction rates, encouraging wider adoption. Multistage surgical planning and long-term follow-up care further support patient confidence. As awareness and access increase, the MTF segment continues to account for a significant share of overall SRS procedures in Europe.
Europe Augmentation Mammoplasty Surgery Market
Augmentation mammoplasty is a key component of gender-affirming surgery for transgender women in Europe. While hormone therapy can promote breast development, many individuals seek surgical enhancement to achieve desired size and symmetry. Improvements in implant materials and surgical techniques have increased safety and aesthetic appeal. Demand is supported by rising acceptance of combined surgical approaches that address multiple aspects of physical transition. This segment benefits from shorter recovery times and relatively high satisfaction rates, making it a widely requested procedure within the broader SRS market.
Europe Genital Surgery Market
Genital surgery represents a central segment of the Europe SRS market, encompassing procedures such as vaginoplasty, phalloplasty, and metoidioplasty. These surgeries are often considered essential for alleviating gender dysphoria and improving quality of life. High procedural complexity requires specialized surgical expertise and multidisciplinary care teams. Continued innovation in reconstructive techniques has improved functional outcomes and reduced complications. Despite high costs and long waiting lists, demand for genital surgery remains strong across Europe.
Europe Voice & Airway Surgery Market
Voice and airway surgery is an increasingly important segment of the European SRS market, particularly for transgender women. Voice pitch and resonance play a critical role in gender expression and social interaction. Surgical interventions complement voice therapy to help individuals achieve vocal characteristics aligned with their gender identity. Growing recognition of voice as a key aspect of transition has increased demand for these procedures. Specialized ENT surgeons and speech therapists support this expanding market segment.
Europe Sex Reassignment Surgery Hospitals Market
Hospitals represent a major setting for sex reassignment surgeries in Europe, particularly for complex and multi-stage procedures. Hospitals offer access to multidisciplinary teams, advanced surgical infrastructure, and post-operative care facilities. Public hospitals often serve as primary providers under national healthcare systems, while private hospitals cater to self-funded patients. Their ability to manage complications and long-term follow-up strengthens patient trust and market growth.
Europe Sex Reassignment Surgery Specialty Clinics Market
Specialty clinics play a growing role in the European SRS market by offering highly specialized, patient-centered care. These clinics often focus exclusively on gender-affirming procedures, providing streamlined treatment pathways and personalized surgical planning. Shorter waiting times and dedicated expertise attract patients seeking faster access and tailored services. Specialty clinics complement hospital-based care and contribute significantly to overall market expansion.
France Sex Reassignment Surgery Market
The sex reassignment surgery market in France is shaped by increasing social acceptance and integration of gender-affirming care within the public healthcare system. France recognizes gender dysphoria as a legitimate medical condition, enabling access to psychological support, hormone therapy, and surgical procedures through regulated care pathways. Public hospitals play a central role in providing sex reassignment surgeries, particularly for complex procedures such as genital reconstruction. While public coverage reduces financial barriers, demand often exceeds capacity, leading to extended waiting periods. This has encouraged growth in private healthcare providers offering faster access and personalized care. France also benefits from skilled surgeons and multidisciplinary medical teams, improving procedural outcomes and patient confidence. Advocacy efforts and legal protections for transgender individuals further support market growth. Overall, the French market demonstrates steady expansion driven by healthcare inclusion, clinical expertise, and rising awareness of gender-affirming treatment options.
United Kingdom Sex Reassignment Surgery Market
The United Kingdom sex reassignment surgery market operates within a structured healthcare framework that emphasizes multidisciplinary assessment and long-term patient support. Gender-affirming surgeries are typically accessed through specialized clinics and hospitals, following defined evaluation and referral pathways. Public healthcare provision plays a significant role, making surgery accessible to many patients; however, long waiting lists remain a major challenge. As a result, private clinics have expanded to meet unmet demand, offering shorter timelines and broader procedural options. Increasing awareness, social acceptance, and legal recognition of transgender rights continue to drive demand for surgical interventions. The UK market also benefits from experienced surgeons and growing specialization in gender-affirming procedures. Despite access challenges, the combination of public and private healthcare provision supports steady market growth, positioning the UK as a key contributor to the European sex reassignment surgery landscape.
Germany Sex Reassignment Surgery Market
Germany represents one of the most advanced sex reassignment surgery markets in Europe, supported by a strong healthcare infrastructure and high clinical standards. The country offers comprehensive gender-affirming care through both public and private healthcare systems, with access to experienced surgeons and modern surgical facilities. Germany is particularly known for expertise in complex reconstructive procedures, attracting both domestic and international patients. Insurance coverage for sex reassignment surgery reduces financial barriers, although strict assessment and documentation requirements can extend treatment timelines. Multidisciplinary care teams, including surgeons, endocrinologists, and mental health professionals, enhance treatment quality and outcomes. Growing social acceptance and legal recognition of gender diversity further contribute to demand. Overall, Germany’s combination of medical excellence, regulatory clarity, and patient trust supports sustained growth in its sex reassignment surgery market.
Market Segmentation
Surgery Type
• Male-to-Female
• Female-to-Male
Surgical Procedure
• Augmentation Mammoplasty
• Genital Surgery
• Facial Feminisation Surgery
• Facial Masculinisation Surgery
• Voice & Airway Surgery
• Body Contouring & Adjunct Procedures
• Others
End User
• Hospitals
• Specialty Clinics
• Ambulatory Surgery Centres
• Others
Countries
• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherlands
• Russia
• Poland
• Greece
• Norway
• Romania
• Portugal
• Rest of Europe
All companies have been covered with 5 Viewpoints
• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis
Company Analysis
• Mount Sinai Health System
• Boston Medical Center
• Rumer Cosmetic Surgery
• The London Transgender Clinic
• Phuket Plastic Surgery Institute
• Gender Surgery Amsterdam (Netherlands)
• UCSF Transgender Care
• Transgender Surgery Institute of America
• Center for Gender Confirmation Serbia
• Papillon Gender Clinic (UK)
Table of Contents
200 Pages
- 1. Introduction
- 2. Research & Methodology
- 2.1 Data Source
- 2.1.1 Primary Sources
- 2.1.2 Secondary Sources
- 2.2 Research Approach
- 2.2.1 Top-Down Approach
- 2.2.2 Bottom-Up Approach
- 2.3 Forecast Projection Methodology
- 3. Executive Summary
- 4. Market Dynamics
- 4.1 Growth Drivers
- 4.2 Challenges
- 5. Europe Sex Reassignment Surgery Market
- 5.1 Historical Market Trends
- 5.2 Market Forecast
- 6. Market Share
- 6.1 By Surgery Type
- 6.2 By Surgical Procedure
- 6.3 By End User
- 6.4 By Countries
- 7. Surgery Type
- 7.1 Male-to-Female
- 7.1.1 Market Analysis
- 7.1.2 Market Size & Forecast
- 7.2 Female-to-Male
- 7.2.1 Market Analysis
- 7.2.2 Market Size & Forecast
- 8. Surgical Procedure
- 8.1 Augmentation Mammoplasty
- 8.1.1 Market Analysis
- 8.1.2 Market Size & Forecast
- 8.2 Genital Surgery
- 8.2.1 Market Analysis
- 8.2.2 Market Size & Forecast
- 8.3 Facial Feminization Surgery
- 8.3.1 Market Analysis
- 8.3.2 Market Size & Forecast
- 8.4 Facial Masculinization Surgery
- 8.4.1 Market Analysis
- 8.4.2 Market Size & Forecast
- 8.5 Voice & Airway Surgery
- 8.5.1 Market Analysis
- 8.5.2 Market Size & Forecast
- 8.6 Body Contouring & Adjunct Procedures
- 8.6.1 Market Analysis
- 8.6.2 Market Size & Forecast
- 8.7 Others
- 8.7.1 Market Analysis
- 8.7.2 Market Size & Forecast
- 9. End User
- 9.1 Hospitals
- 9.1.1 Market Analysis
- 9.1.2 Market Size & Forecast
- 9.2 Specialty Clinics
- 9.2.1 Market Analysis
- 9.2.2 Market Size & Forecast
- 9.3 Ambulatory Surgery Centres
- 9.3.1 Market Analysis
- 9.3.2 Market Size & Forecast
- 9.4 Others
- 9.4.1 Market Analysis
- 9.4.2 Market Size & Forecast
- 10. Countries
- 10.1 France
- 10.1.1 Market Analysis
- 10.1.2 Market Size & Forecast
- 10.2 Germany
- 10.2.1 Market Analysis
- 10.2.2 Market Size & Forecast
- 10.3 Italy
- 10.3.1 Market Analysis
- 10.3.2 Market Size & Forecast
- 10.4 Spain
- 10.4.1 Market Analysis
- 10.4.2 Market Size & Forecast
- 10.5 United Kingdom
- 10.5.1 Market Analysis
- 10.5.2 Market Size & Forecast
- 10.6 Belgium
- 10.6.1 Market Analysis
- 10.6.2 Market Size & Forecast
- 10.7 Netherlands
- 10.7.1 Market Analysis
- 10.7.2 Market Size & Forecast
- 10.8 Russia
- 10.8.1 Market Analysis
- 10.8.2 Market Size & Forecast
- 10.9 Poland
- 10.9.1 Market Analysis
- 10.9.2 Market Size & Forecast
- 10.10 Greece
- 10.10.1 Market Analysis
- 10.10.2 Market Size & Forecast
- 10.11 Norway
- 10.11.1 Market Analysis
- 10.11.2 Market Size & Forecast
- 10.12 Romania
- 10.12.1 Market Analysis
- 10.12.2 Market Size & Forecast
- 10.13 Portugal
- 10.13.1 Market Analysis
- 10.13.2 Market Size & Forecast
- 10.14 Rest of Europe
- 10.14.1 Market Analysis
- 10.14.2 Market Size & Forecast
- 11. Porter’s Five Analysis
- 11.1 Bargaining Power of Buyers
- 11.2 Bargaining Power of Suppliers
- 11.3 Degree of Rivalry
- 11.4 Threat of New Entrants
- 11.5 Threat of Substitutes
- 12. SWOT Analysis
- 12.1 Strength
- 12.2 Weakness
- 12.3 Opportunity
- 12.4 Threat
- 13. Company Analysis
- 13.1 Mount Sinai Health System
- 13.1.1 Overview
- 13.1.2 Key Persons
- 13.1.3 Recent Development
- 13.1.4 SWOT Analysis
- 13.1.5 Revenue
- 13.2 Boston Medical Center
- 13.2.1 Overview
- 13.2.2 Key Persons
- 13.2.3 Recent Development
- 13.2.4 SWOT Analysis
- 13.2.5 Revenue
- 13.3 Rumer Cosmetic Surgery
- 13.3.1 Overview
- 13.3.2 Key Persons
- 13.3.3 Recent Development
- 13.3.4 SWOT Analysis
- 13.3.5 Revenue
- 13.4 The London Transgender Clinic
- 13.4.1 Overview
- 13.4.2 Key Persons
- 13.4.3 Recent Development
- 13.4.4 SWOT Analysis
- 13.4.5 Revenue
- 13.5 Phuket Plastic Surgery Institute
- 13.5.1 Overview
- 13.5.2 Key Persons
- 13.5.3 Recent Development
- 13.5.4 SWOT Analysis
- 13.5.5 Revenue
- 13.6 Gender Surgery Amsterdam (Netherlands)
- 13.6.1 Overview
- 13.6.2 Key Persons
- 13.6.3 Recent Development
- 13.6.4 SWOT Analysis
- 13.6.5 Revenue
- 13.7 UCSF Transgender Care
- 13.7.1 Overview
- 13.7.2 Key Persons
- 13.7.3 Recent Development
- 13.7.4 SWOT Analysis
- 13.7.5 Revenue
- 13.8 Transgender Surgery Institute of America
- 13.8.1 Overview
- 13.8.2 Key Persons
- 13.8.3 Recent Development
- 13.8.4 SWOT Analysis
- 13.8.5 Revenue
- 13.9 Center for Gender Confirmation Serbia
- 13.9.1 Overview
- 13.9.2 Key Persons
- 13.9.3 Recent Development
- 13.9.4 SWOT Analysis
- 13.9.5 Revenue
- 13.10 Papillon Gender Clinic (UK)
- 13.10.1 Overview
- 13.10.2 Key Persons
- 13.10.3 Recent Development
- 13.10.4 SWOT Analysis
- 13.10.5 Revenue
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
